Identification of key signaling pathways and novel computational drug target for oral cancer, metabolic disorders and periodontal disease
Open Access
- 22 October 2024
- journal article
- research article
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 22 (4) , 100431
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeuticsCritical Reviews in Oncology/Hematology, 2024
- Exploring animal models in oral cancer research and clinical intervention: A critical reviewVeterinary Medicine and Science, 2023
- Photodynamic therapy in oral cancer: a review of clinical studiesMedical Oncology, 2023
- Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An updateEuropean Journal of Pharmacology, 2021
- The current markers of cancer stem cell in oral cancersLife Sciences, 2020
- Prediction of drug-target interaction based on protein features using undersampling and feature selection techniques with boostingAnalytical Biochemistry, 2020
- Shared genetic and epigenetic mechanisms between chronic periodontitis and oral squamous cell carcinomaOral Oncology, 2018
- Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesitySurgery for Obesity and Related Diseases, 2011
- Risk factors for cardiovascular disease in patients with periodontitisEuropean Heart Journal, 2003
- Influence of obesity and hypertension on the severity of periodontitis in ratsOral Surgery, Oral Medicine, Oral Pathology, 1977